Bilgir O.Calan M.Bilgir F.Cagliyan G.Arslan O.2024-07-222024-07-22201318781683http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17261Acute lymphoblastic leukemia (ALL) is a malignant disorder resulting from the clonal proliferation of lymphoid precursors with arrested maturation. l-asparaginase is commonly used in combination chemotherapy of both pediatric and adult acute lymphoblastic leukemias. The most commonly encountered side effects of l-asparaginase are hypersensitivity reactions like pyrexia, urticaria, skin rash, and respiratory distress. There are also other side effects like anaphylaxis, coagulopathy, pancreatitis, thrombosis, and hepatic toxicity. Plasmapheresis can sometimes be appropriate to manage an overdose of drugs that circulate in the plasma compartment. We have reported plasmapheresis treatment of fulminant hepatitis in a patient with ALL after l-asparaginase treatment. © 2013 Elsevier Ltd.EnglishAntineoplastic AgentsAsparaginaseDrug-Induced Liver InjuryFemaleHumansLiver Failure, AcuteMiddle AgedPlasma ExchangePrecursor Cell Lymphoblastic Leukemia-LymphomaFulminant hepatic failurel-AsparaginasePlasmapheresisasparaginasedaunorubicinprednisonevincristineantineoplastic agentasparaginaseacute lymphoblastic leukemiaadultarticlebilirubin blood levelbone marrow biopsycancer combination chemotherapycase reportdrug dose reductionfatiguefemalefeverhepatitishumanplasmapheresisside effecttreatment responseacute liver failureacute lymphoblastic leukemiachemically induced disorderfulminant hepatic failurel-Asparaginasemiddle agedtoxic hepatitisArticle10.1016/j.transci.2013.06.010